2024-11-17 21:29:00
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering
Corporate/ 2023-07-24
Parnell Pharmaceuticals Holdings Ltd Ann...

SYDNEY,Jan. 6,2023-- Parnell Pharmaceuticals Holdings Ltd (OTC Pink® Open Market: PARNF) ("Parnell") today announced the exten...

Double-blind period completes! Primary endpoint analysis of phase 3 clinical trial to be conducted for China's first hormone replacement treatment targeting hypoparathyroidism
Health/ 2023-07-22
Double-blind period completes! Primary e...

Submission of NDA to the NMPA is planned within 2023 at the earliest SHANGHAI,Jan. 6,2023-- VISEN Pharmaceuticals,an innovative biopharmaceu...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release